Literature DB >> 30056176

Cannabis use and the development of tolerance: a systematic review of human evidence.

Marco Colizzi1, Sagnik Bhattacharyya2.   

Abstract

Previous studies have reported conflicting results in terms of acute effects of cannabis in man. Independently of other factors, such discrepancy may be attributable to the different cannabis use history of study volunteers. It is thought that regular cannabis users may develop tolerance to the effects of acute cannabis administration. Here we systematically review all studies examining the effects of single or repeated cannabinoid administration in man as a function of previous cannabis exposure. Research evidence tends to suggest that the acute effects of single cannabinoid administration are less prominent in regular cannabis users compared to non-regular users. Studies of repeated cannabinoid administration more consistently suggest less prominent effects upon repeated exposure. Cognitive function is the domain showing the highest degree of tolerance, with some evidence of complete absence of acute effect (full tolerance). The acute intoxicating, psychotomimetic, and cardiac effects are also blunted upon regular exposure, but to a lesser extent (partial tolerance). Limited research also suggests development of tolerance to other behavioral, physiological, and neural effects of cannabis.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cannabinoid receptor type 1; Cannabis; Delta-9-tetrahydrocannabinol; Health; Tolerance

Mesh:

Substances:

Year:  2018        PMID: 30056176     DOI: 10.1016/j.neubiorev.2018.07.014

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  21 in total

1.  Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study.

Authors:  Christine A Rabinak; Ashley Blanchette; Nicole L Zabik; Craig Peters; Hilary A Marusak; Allesandra Iadipaolo; Farrah Elrahal
Journal:  Psychopharmacology (Berl)       Date:  2020-03-11       Impact factor: 4.530

Review 2.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

3.  Sample entropy discriminates balance performance of older cannabis users from non-users.

Authors:  Craig D Workman; Jacob J Sosnoff; Thorsten Rudroff
Journal:  Clin Biomech (Bristol, Avon)       Date:  2022-02-04       Impact factor: 2.063

4.  Simulated driving performance among daily and occasional cannabis users.

Authors:  Ashley Brooks-Russell; Tim Brown; Kyle Friedman; Julia Wrobel; John Schwarz; Gregory Dooley; Karen A Ryall; Benjamin Steinhart; Elise Amioka; Gary Milavetz; George Sam Wang; Michael J Kosnett
Journal:  Accid Anal Prev       Date:  2021-08-14

Review 5.  A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.

Authors:  Rachel Little; Dale D'Mello
Journal:  Innov Clin Neurosci       Date:  2022 Jul-Sep

Review 6.  Cannabis and driving ability.

Authors:  Eric L Sevigny
Journal:  Curr Opin Psychol       Date:  2021-03-17

7.  A Large-Scale Naturalistic Examination of the Acute Effects of Cannabis on Pain.

Authors:  Carrie Cuttler; Emily M LaFrance; Rebecca M Craft
Journal:  Cannabis Cannabinoid Res       Date:  2020-10-23

Review 8.  Workplace Cannabis Policies: A Moving Target.

Authors:  Mia C Hazle; Kevin P Hill; Laurence M Westreich
Journal:  Cannabis Cannabinoid Res       Date:  2020-11-13

9.  Associations of mode of administration on cannabis consumption and subjective intoxication in daily life.

Authors:  Renee M Cloutier; Brian H Calhoun; Ashley N Linden-Carmichael
Journal:  Psychol Addict Behav       Date:  2021-09-02

10.  The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review.

Authors:  Maryam Sorkhou; Rachel H Bedder; Tony P George
Journal:  Front Psychiatry       Date:  2021-02-16       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.